Your browser doesn't support javascript.
loading
Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study.
Stagg, Helen R; Brown, James; Ibraim, Elmira; Riekstina, Vija; Viiklepp, Piret; Cirule, Andra; Cocei, Horia; Danilovits, Manfred; Dravniece, Gunta; Jackson, Charlotte; White, Peter J.
Afiliación
  • Stagg HR; Research Department of Infection and Population Health, University College London, London, United Kingdom.
  • Brown J; Centre for Respiratory Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Ibraim E; Division of Medicine, University College London, London, United Kingdom.
  • Riekstina V; Marius Nasta Institute of Pulmonology, Bucharest, Romania.
  • Viiklepp P; Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia.
  • Cirule A; University of Latvia, Riga, Latvia.
  • Cocei H; Estonian Tuberculosis Registry, National Institute for Health Development, Tallinn, Estonia.
  • Danilovits M; Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia.
  • Dravniece G; Marius Nasta Institute of Pulmonology, Bucharest, Romania.
  • Jackson C; Lung Clinic, Tartu University Hospital, Tartu, Estonia.
  • White PJ; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
PLoS One ; 10(11): e0142425, 2015.
Article en En | MEDLINE | ID: mdl-26558611
ABSTRACT
Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate drug susceptibility testing and drug susceptibility testing data are vital to inform the development of comprehensive, flexible, multidrug resistant tuberculosis guidance.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido
...